Journal
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Volume 93, Issue 2, Pages 201-206Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/jnnp-2021-327520
Keywords
ALS; neurogenetics; motor neuron disease
Categories
Funding
- National Research Foundation (NRF) - Ministry of Science [2017M3C7A1025364, 2017M3C7A1025366]
- Swedish Brain Foundation [2012-0262, 2012-0305, 2013-0279, 2016-0303, 2020-0353]
- Swedish Research Council [2012-3167, 2017-03100]
- Knut and Alice Wallenberg Foundation [2012.0091, 2014.0305, 2020.0232]
- Ulla-Carin Lindquist Foundation
- Neuroforbundet Association
- Umea University Insamlingsstiftelsen [223-2808-12, 223-1881-13, 2.1.12-1605-14]
- Vasterbotten County Council
- Swedish Brain Power
- King Gustaf V:s and Queen Victoria's Freemason's Foundation
- National Research Foundation of Korea [2017M3C7A1025366, 2017M3C7A1025364] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
Ask authors/readers for more resources
De novo mutations in SOD1 have been identified as a cause of sporadic ALS, potentially impacting both isolated cases and smaller familial groups. While the exact origin of these mutations remains uncertain, the findings suggest the importance of genetic counseling and screening for all ALS patients to potentially benefit from personalized therapy.
Objective The only identified cause of amyotrophic lateral sclerosis (ALS) are mutations in a number of genes found in familial cases but also in sporadic cases. De novo mutations occurring in a parental gonadal cell, in the zygote or postzygotic during embryonal development can result in an apparently sporadic/isolated case of ALS later in life. We searched for de novo mutations in SOD1 as a cause of ALS. Methods We analysed peripheral-blood exome, genome and Sanger sequencing to identify deleterious mutations in SOD1 in 4000 ALS patients from Germany, South Korea and Sweden. Parental kinship was confirmed using highly polymorphic microsatellite markers across the genome. Medical genealogical and clinical data were reviewed and compared with the literature. Results We identified four sporadic ALS cases with de novo mutations in SOD1. They aggregate in hot-spot codons earlier found mutated in familial cases. Their phenotypes match closely what has earlier been reported in familial cases with pathogenic mutations in SOD1. We also encountered familial cases where de novo mutational events in recent generations may have been involved. Conclusions De novo mutations are a cause of sporadic ALS and may also be underpinning smaller families with few affected ALS cases. It was not possible to ascertain if the origin of the de novo mutations was parental germline, zygotic or postzygotic during embryonal development. All ALS patients should be offered genetic counselling and genetic screening, the challenges of variant interpretation do not outweigh the potential benefits including earlier confirmed diagnosis and possible bespoken therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available